IMR Press / FBL / Volume 8 / Issue 6 / DOI: 10.2741/1190

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

How does diabetes accelerate atherosclerotic plaque rupture and arterial occlusion?
Show Less
1 Department of Pathology, University of Washington School of Medicine, Seattle WA 98195-7470, USA
Front. Biosci. (Landmark Ed) 2003, 8(6), 1371–1383;
Published: 1 September 2003

Risk factors for atherosclerosis, including diabetes, have been identified for many years, and, especially for lipids, we now know a great deal about how these factors contribute to the early lesion. In contrast, the mechanism or mechanisms linking these factors to the final events in atherosclerosis, that is plaque rupture and thrombotic occlusion, have remained largely speculative. This speculation has been because of a lack the ability to visualize fragile, advanced lesions in humans and a lack of animal models. Recently, however, magnetic resonance imaging tools have begun to visualize the advanced lesion and animal models with features of plaque rupture have been characterized. Thus the opportunity exists to test hypotheses linking diabetes to events in the advanced plaques. This review summarizes our current knowledge of the processes that may be responsible for increased plaque rupture and occlusion associated with diabetes.

Back to top